loading...

Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions

Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions

August 4, 2022

Our partners Felipe Mesquita and Rob Rodrigues, and attorney at law Carolina Mendes had their article “Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions” published this Thursday (August 4), by the “Kluwer Patent Blog” website. It addresses recent decisions in litigation involving pharma patents that honor the protection of industrial property rights despite the public health challenges faced in Brazil. Full article at: http://patentblog.kluweriplaw.com/2022/08/04/biotechnology-pharma-patent-litigation-in-brazil-an-update-on-preliminary-injunctions/

Felipe Mesquita e Roberto Rodrigues sócios do Licks Attorneys e Carolina Mendes, advogada, tiveram seu artigo “Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions” publicado hoje (4/8), no site “Kluwer Patent Blog”. O artigo aborda recentes decisões em litígios envolvendo patentes farmacêuticas que prestigiam a proteção aos direitos de propriedade industrial apesar dos desafios de saúde pública enfrentados no Brasil. Leia o texto na íntegra: http://patentblog.kluweriplaw.com/2022/08/04/biotechnology-pharma-patent-litigation-in-brazil-an-update-on-preliminary-injunctions/